Literature DB >> 18059557

Evidence of the modulation of mRNA splicing fidelity in humans by oxidative stress and p53.

Kim Disher1, Adonis Skandalis.   

Abstract

The majority of human genes generate mRNA splice variants and while there is little doubt that alternative splicing is an important biological phenomenon, it has also become apparent that some splice variants are associated with disease. To elucidate the molecular mechanisms responsible for generating aberrant splice variants, we have investigated alternative splicing of the human genes HPRT and POLB following oxidative stress in different genetic backgrounds. Our study revealed that splicing fidelity is sensitive to oxidative stress. Following treatment of cells with H2O2, the overall frequency of aberrant, unproductive splice variants increased in both loci. At least in POLB, splicing fidelity is p53 dependent. In the absence of p53, the frequency of POLB splice variants is elevated but oxidative stress does not further increase the frequency of splice variants. Our data indicate that mis-splicing following oxidative stress represents a novel and significant genotoxic outcome and that it is not simply DNA lesions induced by oxidative stress that lead to mis-splicing but changes in the alternative splicing machinery itself.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059557     DOI: 10.1139/g07-074

Source DB:  PubMed          Journal:  Genome        ISSN: 0831-2796            Impact factor:   2.166


  11 in total

1.  The adaptive significance of unproductive alternative splicing in primates.

Authors:  Adonis Skandalis; Mark Frampton; Jon Seger; Miriam H Richards
Journal:  RNA       Date:  2010-08-18       Impact factor: 4.942

2.  Characterization of DNA polymerase beta splicing variants in gastric cancer: the most frequent exon 2-deleted isoform is a non-coding RNA.

Authors:  Valeria Simonelli; Mariarosaria D'Errico; Domenico Palli; Rajendra Prasad; Samuel H Wilson; Eugenia Dogliotti
Journal:  Mutat Res       Date:  2009-07-25       Impact factor: 2.433

3.  ROS and p53 in regulation of UVB-induced HDM2 alternative splicing.

Authors:  Lingying Tong; Shiyong Wu
Journal:  Photochem Photobiol       Date:  2014-07-26       Impact factor: 3.421

4.  Characterizing the Genetic Basis for Nicotine Induced Cancer Development: A Transcriptome Sequencing Study.

Authors:  Jasmin H Bavarva; Hongseok Tae; Robert E Settlage; Harold R Garner
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

5.  Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes.

Authors:  David A Knowles; Courtney K Burrows; John D Blischak; Kristen M Patterson; Daniel J Serie; Nadine Norton; Carole Ober; Jonathan K Pritchard; Yoav Gilad
Journal:  Elife       Date:  2018-05-08       Impact factor: 8.140

6.  The Pol β variant containing exon α is deficient in DNA polymerase but has full dRP lyase activity.

Authors:  Da-Peng Dai; Rajendra Prasad; Phyllis R Strauss; Samuel H Wilson
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

7.  The transcript expression levels of HNRNPM, HNRNPA0 and AKAP17A splicing factors may be predictively associated with ageing phenotypes in human peripheral blood.

Authors:  Benjamin P Lee; Luke C Pilling; Stefania Bandinelli; Luigi Ferrucci; David Melzer; Lorna W Harries
Journal:  Biogerontology       Date:  2019-07-10       Impact factor: 4.277

8.  A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes.

Authors:  Natalia N Singh; Joonbae Seo; Sarah J Rahn; Ravindra N Singh
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

Review 9.  The spliceosome as target for anticancer treatment.

Authors:  R J van Alphen; E A C Wiemer; H Burger; F A L M Eskens
Journal:  Br J Cancer       Date:  2008-11-25       Impact factor: 7.640

10.  Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.

Authors:  Joonbae Seo; Natalia N Singh; Eric W Ottesen; Senthilkumar Sivanesan; Maria Shishimorova; Ravindra N Singh
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.